{"id":42499,"date":"2022-05-25T11:05:18","date_gmt":"2022-05-25T11:05:18","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=92313"},"modified":"2022-05-25T11:05:18","modified_gmt":"2022-05-25T11:05:18","slug":"seegene-unveils-12-pcr-testing-initiative-to-help-end-covid-19-pandemic","status":"publish","type":"post","link":"https:\/\/southafricajournal.com\/seegene-unveils-12-pcr-testing-initiative-to-help-end-covid-19-pandemic\/","title":{"rendered":"Seegene unveils \u2018$12 PCR testing\u2019 initiative to help end COVID-19 pandemic"},"content":{"rendered":"
\n
\n
\n

Includes asymptomatic testing at community-based facilities to prevent widespread transmissions<\/p>\n

Regular testing for COVID-19, flu, RSV crucial for staying safe as anti-virus restrictions are eased<\/p>\n

PCR tests will be priced affordably, made possible through Seegene’s 20 years of expertise<\/p>\n

“Full support for countries that join Seegene’s campaign to ensure safe return to normalcy”<\/p>\n

SEOUL, South Korea, May 25, 2022 \/PRNewswire\/ — Seegene Inc.<\/b> (KQ096530), South Korea’s leading molecular diagnostics (MDx) company, today unveiled a global initiative for preemptive and routine PCR testing to help individuals stay safe and healthy while living in the COVID-19 era. Dr. Jong-Yoon Chun, CEO of Seegene, says the initiative is designed to help people safely return to normalcy and contribute to global efforts to terminate COVID-19 and prevent future outbreaks.<\/p>\n

\"Logo\"<\/div>\n

There have been reports of an uptick in influenza and everyday colds which had been absent during the two-year pandemic, as countries worldwide ease social distancing restrictions and lift mask mandates. Experts have also warned that potentially dangerous mutations could go unnoticed due to scaled down PCR testing with governments no longer providing them for free. Individuals are now required to monitor their health at their own expense to stay safe.<\/p>\n

Seegene’s initiative dubbed ‘In-life PCR<\/i>,’ entails 1) asymptomatic testing for early virus detection 2) syndromic respiratory testing as anti-virus restrictions are eased and 3) boosting PCR test accessibility through affordable pricing.<\/p>\n